Metraipolis › archive › dc_c3faed6c792d

Iguratimod in Autoimmune Diseases: Emerging Evidence for its Immunomodulatory and Therapeutic Role — Europe PMC PMID:42756681

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42756681
DOI
10.31138/mjr.060925.iar
License (as archived)
solo-consultazione
Archived
2026-11-01T12:53:18.547Z
SHA-256 of the archived text
0eca242068cab90ab5efafa9c92d781ae1271a1523ea98e377fe1e638f6c0b8d
Stable URL of this page
https://metraipolis.com/documento/dc_c3faed6c792d

How to cite

Iguratimod in Autoimmune Diseases: Emerging Evidence for its Immunomodulatory and Therapeutic Role — Europe PMC PMID:42756681 — Europe PMC (en), https://europepmc.org/article/MED/42756681 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c3faed6c792d (Metraipolis archive dc_c3faed6c792d, sha256 0eca242068cab90ab5efafa9c92d781ae1271a1523ea98e377fe1e638f6c0b8d)
BibTeX
@misc{dcc3faed6c792d,
  title = {Iguratimod in Autoimmune Diseases: Emerging Evidence for its Immunomodulatory and Therapeutic Role — Europe PMC PMID:42756681},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42756681},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c3faed6c792d; sha256 0eca242068cab90ab5efafa9c92d781ae1271a1523ea98e377fe1e638f6c0b8d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42756681. Agents can read the archived copy with the MCP tool read_document.